Ramucirumab-induced Multiple Haemangiomas of the Skin: Two Case Reports

MeSH terms

• Aged
• Antibodies, Monoclonal / adverse effects*
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents / adverse effects*
• Biopsy
• Cecal Neoplasms / drug therapy*
• Drug Substitution
• Female
• Hemangioma, Capillary / chemically induced*
• Hemangioma, Capillary / pathology
• Hemangioma, Capillary / surgery
• Humans
• Lung Neoplasms / drug therapy*
• Middle Aged
• Panitumumab
• Ramucirumab
• Skin Neoplasms / chemically induced*
• Skin Neoplasms / pathology
• Skin Neoplasms / surgery
• Treatment Outcome